Jennison Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-99,802
| Closed | -$105M | – | 625 |
|
2024
Q2 | $105M | Buy |
99,802
+66,281
| +198% | +$69.7M | 0.07% | 119 |
|
2024
Q1 | $32.3M | Buy |
+33,521
| New | +$32.3M | 0.02% | 284 |
|
2023
Q2 | – | Sell |
-28,090
| Closed | -$23.1M | – | 616 |
|
2023
Q1 | $23.1M | Buy |
+28,090
| New | +$23.1M | 0.02% | 311 |
|
2021
Q4 | – | Sell |
-1,805
| Closed | -$1.09M | – | 715 |
|
2021
Q3 | $1.09M | Buy |
+1,805
| New | +$1.09M | ﹤0.01% | 597 |
|
2021
Q2 | – | Sell |
-10,061
| Closed | -$4.76M | – | 713 |
|
2021
Q1 | $4.76M | Buy |
+10,061
| New | +$4.76M | ﹤0.01% | 475 |
|
2020
Q4 | – | Sell |
-66,884
| Closed | -$37.4M | – | 680 |
|
2020
Q3 | $37.4M | Sell |
66,884
-1,673
| -2% | -$937K | 0.03% | 226 |
|
2020
Q2 | $42.8M | Buy |
68,557
+22,157
| +48% | +$13.8M | 0.04% | 190 |
|
2020
Q1 | $22.7M | Buy |
+46,400
| New | +$22.7M | 0.03% | 239 |
|
2019
Q3 | – | Sell |
-3,332
| Closed | -$1.04M | – | 678 |
|
2019
Q2 | $1.04M | Sell |
3,332
-83
| -2% | -$26K | ﹤0.01% | 549 |
|
2019
Q1 | $1.4M | Buy |
+3,415
| New | +$1.4M | ﹤0.01% | 515 |
|
2018
Q2 | – | Sell |
-88,815
| Closed | -$30.6M | – | 700 |
|
2018
Q1 | $30.6M | Buy |
88,815
+13,022
| +17% | +$4.48M | 0.03% | 331 |
|
2017
Q4 | $28.5M | Sell |
75,793
-1,123,954
| -94% | -$423M | 0.03% | 344 |
|
2017
Q3 | $536M | Sell |
1,199,747
-93,116
| -7% | -$41.6M | 0.55% | 47 |
|
2017
Q2 | $635M | Buy |
1,292,863
+532,547
| +70% | +$262M | 0.67% | 41 |
|
2017
Q1 | $295M | Sell |
760,316
-1,156,625
| -60% | -$448M | 0.32% | 55 |
|
2016
Q4 | $704M | Sell |
1,916,941
-205,207
| -10% | -$75.3M | 0.79% | 33 |
|
2016
Q3 | $853M | Buy |
2,122,148
+91,223
| +4% | +$36.7M | 0.92% | 32 |
|
2016
Q2 | $709M | Sell |
2,030,925
-20,934
| -1% | -$7.31M | 0.78% | 35 |
|
2016
Q1 | $740M | Buy |
2,051,859
+35,832
| +2% | +$12.9M | 0.78% | 39 |
|
2015
Q4 | $1.09B | Buy |
2,016,027
+93,894
| +5% | +$51M | 1.07% | 25 |
|
2015
Q3 | $894M | Buy |
1,922,133
+189,407
| +11% | +$88.1M | 0.92% | 28 |
|
2015
Q2 | $884M | Buy |
+1,732,726
| New | +$884M | 0.81% | 35 |
|